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HydrocepHalus is the most common neurosurgical condition in children; the congenital form affects 0.5–1 per 1000 live births, and the neonatal ac-
quired form affects 3–5 per 1000 live births.15 It is also the 
most common surgically correctable clinical condition in 
the pediatric population worldwide.8 The prevalence of hy-
drocephalus is greatest in low- and middle-income coun-
tries (LMICs), where access to neurosurgical care is lim-
ited. This predisposition is attributed to higher birth rates, 
poor prenatal care, and a higher incidence of meningitis in 
the perinatal and neonatal period. While specific epidemi-
ology of hydrocephalus is not available for every country 
in Sub-Saharan Africa, the annual incidence of hydro-
cephalus in Sub-Saharan Africa is approximately 145 per 
100,000 births, which is almost twice the rate found in in-
dustrialized nations.2,5,19 Hydrocephalus accounts for 32% 
of congenital neurosurgical conditions in Nigeria and 59% 
of all neurosurgical conditions in Uganda.15
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OBJECTIVE Hydrocephalus is the most common pediatric neurosurgical condition, with a high prevalence in low- and 
middle-income countries. Untreated, hydrocephalus leads to neurological disability or death. The epidemiology and out-
comes of hydrocephalus treated by ventriculoperitoneal (VP) shunts in Sub-Saharan Africa are not well defined and vary 
by region. The aim of the present study was to examine the mortality and morbidity rates and predictors of mortality in 
children treated by VP shunt placement for hydrocephalus at Kamuzu Central Hospital in Lilongwe, Malawi.
METHODS This is a prospective study of 100 consecutive children presenting with hydrocephalus who were treated 
with VP shunt placement from January 2015 to August 2017. Demographics, nutritional status, maternal characteristics, 
developmental delay, shunt complications, readmissions, and in-hospital and 3-month mortality data were collected. 
Multivariate logistic regression was used to identify predictors of death within 3 months of surgery.
RESULTS Overall, 46% of participants were female, with an average age of 5.4 ± 3.7 months at the time of surgery. 
The majority of patients were term deliveries (87.8%) and were not malnourished (72.9%). Only 10.8% of children were 
diagnosed with meningitis before admission. In-hospital and 3-month mortality rates were 5.5% and 32.1%, respectively. 
The only significant association with mortality was maternal age, with older maternal age demonstrating decreased odds 
of 3-month mortality (OR 0.9, 95% CI 0.8–1.0, p = 0.045).
CONCLUSIONS Surgical management of hydrocephalus with VP shunts portends a high mortality rate in Malawi. The 
association of younger maternal age with mortality is likely a proxy for social determinants, which appear to contribute 
as much to mortality as patient factors. VP shunting is inadequate as a sole surgical management of hydrocephalus in 
resource-limited settings.
https://thejns.org/doi/abs/10.3171/2019.2.PEDS18325
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Most cases of pediatric hydrocephalus in Sub-Saharan 
Africa are classified as obstructive, and common causes 
include spina bifida and postinfectious acquired hydro-
cephalus. In contrast, the most common etiologies in high-
income countries (HICs) are congenital and prematurity-
related intraventricular hemorrhage.15 The treatment rate 
of pediatric hydrocephalus in Sub-Saharan Africa was 
recently estimated to be less than 10%.19 Untreated hydro-
cephalus can result in permanent neurological disability 
and death.13,22 In a 1962 study of the natural history of un-
treated hydrocephalus based on 182 cases, the chances that 
a hydrocephalic child diagnosed soon after birth would 
survive to adulthood were estimated to be 20%–23%, ris-
ing to 26% for children evaluated at 3 months, and 50% 
for children who survived to at least 1 to 2 years of age. 
The overall mortality rate during the 20 years of the study 
was 49%. Only 32% of surviving children displayed full 
physical functioning, with 48% showing severe disability.13 
Even with treatment, outcomes in the developing world 
can be unsatisfactory, with one study reporting that 60% 
of patients had poor outcomes when rated based on visual, 
motor, and seizure criteria.10
Treatment of hydrocephalus in LMICs is limited by 
lack of resources, neurosurgical personnel, and infrastruc-
ture.15 The current standard of pediatric hydrocephalus 
care in Malawi, as in other nations, is ventriculoperitoneal 
(VP) shunt placement. VP shunts are prone to complica-
tions and require close monitoring. VP shunt obstruction, 
migration, and infection are common complications that 
require revision or replacement. Because of this, children 
with VP shunts require more resources for both acute and 
long-term management than do children with other con-
ditions managed in hospitals.15 Even in HICs, where VP 
shunt procedures represent a very small percentage of 
overall pediatric procedures performed, they account for 
the second-highest rate of hospital admissions in pediat-
ric patients.9 VP shunt failure reaches 50% at 2 years in 
HICs, with an infection rate of 4.1%–20.5%.6,20 In spite of 
the complications of VP shunt placement, studies in HICs 
show that it represents an economically and socially effec-
tive intervention for this morbid condition.15,18 Given the 
resource constraints and difficulties faced by Sub-Saharan 
African families seeking care for initial and subsequent 
hydrocephalus complications, the mortality and morbidity 
rates associated with pediatric hydrocephalus in this set-
ting are likely much higher than in the developing world.4,15
Currently, very limited data are available regarding the 
long-term outcomes of Sub-Saharan African children fol-
lowing VP shunt placement. Given the paucity of data in 
this region, we sought to characterize outcomes, as well as 
patient and social characteristics leading to poor outcomes 
in a resource-limited setting. The aim of our study was to 
examine the mortality and morbidity rates and predictors 
of mortality in children treated for hydrocephalus with VP 
shunt placement at the Kamuzu Central Hospital (KCH) in 
Lilongwe, Malawi.
Methods
This is a prospective study of 100 children (less than 18 
years of age) presenting consecutively with hydrocepha-
lus who were treated with VP shunt placement at KCH 
in Lilongwe, Malawi, from January 2015 to August 2017. 
KCH, one of four tertiary referral centers in Malawi, has 
an approximate catchment area of 6 million people, 900 
beds, and two clinical officers who perform VP shunt 
placements, with 5 and 8 years of shunt surgery experi-
ence. A neurosurgeon was available at KCH during the 
study period. A pediatric step-down unit is available, but 
there is no pediatric intensive care unit. Available imag-
ing modalities include head ultrasound and, intermittently, 
CT; hydrocephalus patients do not currently undergo CT 
or MRI evaluation.
The primary outcomes of interest were postoperative 
mortality following VP shunt surgery, specifically in-hos-
pital and 3-month mortality rates after surgery. Second-
ary outcomes included 6-month mortality, hospital read-
mission, shunt infection, shunt malfunction/malposition, 
excessive CSF drainage, child growth, and the presence 
of developmental delay or disability. As almost 50% of 
patients lacked mortality data at the 6-month point, these 
data were not used as a primary outcome.
The secondary outcomes were determined by the clini-
cal officers in the hospital or at the time of follow-up via 
home visits. Shunt infection was defined by the Infectious 
Society of America’s practice guidelines, including ery-
thema or tenderness over the shunt; new-onset headache, 
nausea, lethargy, or change in mental status in the appro-
priate clinical context; bacteremia without other identified 
source; or signs or symptoms of peritonitis in the absence 
of another cause.23 Exposed shunts were considered sus-
pected infections and all underwent revision. Child growth 
was determined by adherence to the child’s growth curve 
based on the WHO growth charts for head circumference, 
length, and weight. Developmental delay was defined as 
the child not meeting one of the Centers for Disease Con-
trol and Prevention developmental milestones for his or her 
age group.3
Variables collected include baseline demographic and 
clinical characteristics of the children, such as age at time 
of VP shunt insertion, sex, weight, maternal and paternal 
age and medical history, nutritional status, prematurity (de-
livered earlier than 37 weeks’ gestation), mode of delivery, 
reason for presentation, head circumference, and opening 
pressure, as well as secondary outcomes. The determina-
tion of nutritional status was based on birth weight for age 
or clinical findings of temporal wasting or scaphoid abdo-
men. Head circumference measures depend on a number 
of variables including age and sex, thus standard WHO 
z-scores for head circumference were used. Opening pres-
sure was defined as normal, moderate, or high based on
the clinical judgment of the clinical officers inserting the
shunts. Prior treatment of meningitis was documented as
well, but the etiology of hydrocephalus was difficult to as-
sess in this resource-poor setting and any history of recent
febrile illness was confounded by a high incidence of ma-
larial and diarrheal disease. We used the median age of 25
year to categorize maternal age as older and younger. Birth
weight was categorized using the WHO’s birth weight
standard classification.
All data, including follow-up, were collected by a se-
nior data clerk. Follow-up visits and examinations were 
conducted by a senior data clerk by home visit at the last 
known address of residence for the child. The clerk ini-
tially called families via the cell phone number on file. If 
this method was not successful, the clerk would visit the 
last known address. If the family no longer was present 
at the address, the clerk would contact the village elders 
to determine a new address. Follow-up data were avail-
able for 91% of patients during hospitalization; 81% of pa-
tients at 3 months; and 53% of patients at 6 months (Fig. 
1). Follow-up in a resource-poor setting is difficult and 
major barriers in Malawi included movement of families 
to Mozambique, poor reporting by family members, and 
the degree of investment and documentation performed 
by the clerks. These factors account for variable follow-
up at 6 months and even during hospitalization. Addition-
ally, families absconding from the hospital or transferring 
hospitals affected completeness of in-hospital data. Cause 
of death proved incredibly difficult to assess given family 
reporting and budgetary constraints, to the point that these 
data were not meaningful.
Sample size was affected by numerous factors, includ-
ing budgetary and time constraints; however, 100 patients 
were determined to be an adequate representative popula-
tion based on similar sample sizes among other studies in 
resource-poor areas.4,8,10,16,17 Bivariate analysis compared 
patient and parental characteristics by mortality status 
at 3 months. We also present patients’ adverse outcomes 
in-hospital and at 3 months postsurgery. We used the chi-
square and Fisher’s exact tests to compare categorical vari-
ables, and the Kruskal-Wallis test to compare medians of 
nonnormally distributed continuous variables (patient’s 
age at surgery, father’s age, and head circumference z-
score.) The Kruskal-Wallis tests were found to be equiva-
lent to the Mann-Whitney U-test.
We used multivariable logistic regression to calculate 
odds ratios and 95% confidence intervals for the associa-
tion between 3 potential predictors of 3-month mortality 
determined a priori based on knowledge of risk factors 
and consideration of bivariate analysis: nutritional status, 
age in months at time of surgery, and mother’s age. Fur-
thermore, we calculated the area under the receiver operat-
ing characteristic (ROC) curve, to determine if our model 
adequately predicted mortality at 3 months. We used the 
Hosmer-Lemeshow goodness-of-fit test to assess our mod-
el fit. A p value of less than 0.05 was used to determine sta-
tistical significance. Analyses were conducted using SAS 
statistical software (version 9.4; SAS Institute Inc.).
This protocol was approved by both the Malawian Na-
tional Health Services Research Council and the Univer-
sity of North Carolina at Chapel Hill Institutional Review 
Board. Informed consent for this data collection was ob-
tained from families in their primary language, and all 
were free to withdraw from the study at any point.
Results
Of the 100 patients undergoing VP shunt placement, 
46 (46.0%) were female. The median age at the time of 
surgery was 4.5 months (IQR 3.0–7.0 months). Fifty-nine 
(74.7%) of 79 participants had a birth weight at or above 
FIG. 1. Patient follow-up over 6 months. aPatients were lost to follow-up despite attempts to reach them by cell phone, home visit, 
and asking the village elder. Figure is available in color online only.
TABLE 1. Patient and parental characteristics total and by mortality status
Variable
No. of Patients (%) or Median (IQR)
p ValueTotal (n = 100) Dead by 3 Mos (n = 26) Alive by 3 Mos (n = 55)
Age (mos) 4.5 (3.0–7.0) 4 (3.0–6.0) 5 (3.0–7.0) 0.666
Sex 0.675
 Female 46/100 (46.0%) 11/26 (42.3%) 26/55 (47.3%)
 Male 54/100 (54.0%) 15/26 (57.7%) 29/55 (52.7%)
Mother’s age (yrs) 25 (21–29) 22.5 (20–26) 25 (22–29) 0.027
 <25 47/99 (47.5%) 16/26 (61.5%) 23/54 (42.6%) 0.112
≥25 52/99 (52.5%) 10/26 (38.5%) 31/54 (57.4%)
Father’s age (yrs) 30 (25–35) 26 (24–32) 30 (26–34) 0.251
Mother’s HIV status 0.169
 Positive 7/93 (7.5%) 1/25 (4.0%) 6/53 (11.3%)
 Negative 86/93 (92.5%) 20/25 (80.0%) 47/53 (88.7%)
Folic acid prepregnancy 0.745
 Yes 14/98 (14.3%) 5/25 (20.0%) 8/54 (14.8%)
 No 84/98 (85.7%) 20/25 (80.0%) 46/54 (85.2%)
Teratogenic drug use: alcohol 1.000
 Yes 1/100 (1.0%) 0/24 (0.0%) 1/53 (1.9%)
 No 99/100 (99.0%) 24/24 (100.0%) 52/53 (98.1%)
Delivery mode 0.411
Vaginal delivery 71/96 (74.0%) 22/26 (84.6%) 36/52 (69.2%)
Cesarean section 14/96 (14.6%) 2/26 (7.7%) 9/52 (17.3%)
Assisted vaginal delivery 11/96 (11.5%) 2/26 (7.7%) 7/52 (13.5%)
Gestational age (wks) 0.677
Preterm (<37) 12/98 (12.3%) 3/26 (11.5%) 4/54 (7.4%)
 Term 86/98 (87.8%) 23/26 (88.5%) 50/54 (92.6%)
Birth weight (kg) 1.000
 <2.5 20/79 (25.3%) 4/21 (19.1%) 9/41 (22.0%)
≥2.5 59/79 (74.7%) 17/21 (81.0%) 32/41 (78.0%)
Head circumference (z-score) 9 (5.9–12.0) 7.1 (3.8–10.6) 9.9 (6.2–13.1) 0.031
Nutritional status 0.199
 Nourished 70/96 (72.9%) 8/25 (32.0%) 10/53 (18.9%)
 Malnourished 26/96 (27.1%) 17/25 (68.0%) 43/53 (81.1%)
History of treatment for meningitis
 Yes 10/93 (10.8%) 2/22 (9.1%) 6/51 (11.8%) 0.168
 No 83/93 (89.2%) 20/22 (90.9%) 45/51 (88.2%)
Reasons for presentation at hospital 
Large head 94/99 (95.0%) 24/26 (92.3%) 52/54 (96.3%) 0.592
 Convulsions 22/99 (22.2%) 5/26 (19.2%) 13/54 (24.1%) 0.778
Delayed milestones 5/98 (5.1%) 3/26 (11.5%) 2/54 (3.7%) 0.323
 Vomiting 13/99 (13.1%) 4/26 (15.4%) 6/54 (11.1%) 0.720
 Irritability 26/99 (26.3%) 3/26 (11.5%) 20/54 (37.0%) 0.020
 Infection 24/99 (24.2%) 4/26 (15.4%) 17/54 (31.5%) 0.177
Other reasons 7/99 (7.1%) 1/25 (4.0%) 5/55 (9.1%) 0.660
Ultrasound scan 0.601
 Hydrocephalus 91/91 (100.0%) 25/25 (100.0%) 53/53 (100.0%)
Additional abnormal findings* 8/91 (8.8%) 2/25 (8.0%) 6/53 (11.3%)
Opening pressure (cm H2O) 0.833
 Low/normal 1/71 (1.4%) 0/16 (0.0%) 1/42 (2.4%)
 Moderate 36/74 (48.6%) 9/16 (56.3%) 19/41 (46.3%)
 High 37/74 (50.0%) 7/16 (43.8%) 21/41 (51.2%)
* Additional abnormal findings on ultrasound included hemorrhage, tumor, midline shift, and other infrequent findings.
2.5 kg, and 86 (87.8%) of 98 were term births, with 82 
(85.4%) of 96 undergoing vaginal or vaginal assisted de-
liveries. Only 10 (10.8%) of 93 patients were ever treated 
for meningitis prior to hydrocephalus assessment. Malnu-
trition was present in 26 (27.1%) of 96 patients at the time 
of surgery, with a mean weight at surgery of 6.3 kg (± 2.5 
kg) (Table 1). The median maternal age was 25 years (IQR 
21–29 years), and the median paternal age was 30 years 
(IQR 25–35 years). Seven (7.5%) of 93 mothers were HIV 
positive, 7 (7.5%) of 93 had an unknown HIV status, while 
86 (92.5%) of 93 were HIV negative. Only 14 (14.3%) of 98 
mothers reported folic acid supplementation during preg-
nancy. One (1%) of 100 mothers admitted to alcohol use 
during pregnancy (Table 1).
An ultrasound report was available for 91 of the chil-
dren; no child underwent CT scanning or MRI. Of those 
children with an ultrasound report, hemorrhage was iden-
tified in 1 (1.1%) of 91 patients, midline shift in 7 (7.7%) 
of 91 patients, and 66 (72.5%) of 91 patients had commu-
nicating hydrocephalus. Imaging did not identify any tu-
mors. The opening pressure was moderate for 36 (48.6%) 
of 74 patients and high for 37 (50.0%) of 74 patients. The 
most common reasons for presentation included large head 
in 94 (95.0%) of 99 patients, irritability in 26 (26.3%) of 
99 patients, and convulsions in 22 (22.2%) of 99 patients 
(Table 1).
Five (5.5%) of 91 patients died while in the hospital. Of 
the 81 patients with 3-month postoperative follow-up, 26 
(32.1%) had died. Of the 53 patients with 6-month postop-
erative follow-up, 33 (62.3%) had died. Table 2 shows over-
all and 3-month complications by mortality status. None 
of the complications at 3 months were significantly associ-
TABLE 2. Complications at hospitalization and at the 3-month follow-up
Variable
No. of Patients (%)
p ValueTotal (n = 100) Dead by 3 Mos (n = 26) Alive by 3 Mos (n = 55)
Shunt revision 1.000
 Yes 5/88 (5.7%) 1/22 (4.6%) 3/51 (5.9%)
 No 82/88 (93.2%) 21/22 (95.5%) 48/51 (94.1%)
Cause of shunt revision 0.250
Blocked shunt 1/5 (20.0%) 1/2 (50.0%) 0/3 (0.0%)
Exposed shunt 4/5 (80.0%) 1/2 (50.0%) 3/3 (100.0%)
Reason for longer stay 0.300
Bloody CSF 1/11 (9.1%) 1/3 (33.3%) 0/7 (0.0%)
Hospital operation time 1/11 (9.1%) 0/3 (0.0%) 1/7 (14.3%)
Opening space 1/11 (9.1%) 0/3 (0.0%) 1/7 (14.3%)
Operating space 1/11 (9.1%) 1/3 (33.3%) 0/7 (0.0%)
Operating time 2/11 (18.2%) 1/3 (33.3%) 1/7 (14.3%)
Other infections 1/11 (9.1%) 0/3 (0.0%) 0/7 (0.0%)
 Pneumonia 1/11 (9.1%) 0/3 (0.0%) 1/7 (14.3%)
Shortage of shunt 3/11 (27.3%) 0/3 (0.0%) 3/7 (42.9%)
Overdrainage 1.000
 Yes 1/79 (1.3%) 0/19 (0.0%) 1/47 (2.1%)
 No 78/79 (98.7%) 19/19 (100.0%) 46/47 (97.9%)
Meningitis 1.000
 Yes 3/79 (3.8%) 0/19 (0.0%) 2/47 (4.3%)
 No 76/79 (96.2%) 19/19 (100.0%) 45/47 (95.7%)
Other complications 1.000
Febrile illness 3/100 (3.0%) 1/26 (3.8%) 1/55 (1.8%)
Umbilical hernia 1/100 (1.0%) 0/26 (0.0%) 1/55 (1.8%)
Burst abdomen 1/100 (1.0%) 0/26 (0.0%) 1/55 (1.8%)
VP shunt exposure 0.565
 Yes 4/54 (7.4%) 1/13 (7.7%) 3/33 (9.1%)
 No 50/54 (92.6%) 12/13 (92.3%) 30/33 (90.9%)
Meeting milestones 1.000
 Yes 19/54 (35.2%) 4/13 (30.8%) 12/33 (36.4%)
 No 35/54 (64.8%) 9/13 (69.2%) 21/33 (63.6%)
Eating better 1.000
 Yes 34/54 (63.0%) 9/13 (69.2%) 21/33 (63.6%)
 No 20/54 (37.0%) 4/13 (30.8%) 12/33 (36.4%)
ated with mortality. In-hospital complications included one 
patient with overdrainage of CSF, one patient with menin-
gitis, and one patient with an exposed shunt the same day 
of placement who underwent immediate revision. Of the 4 
(8.7%) of 46 patients who had documentation of an exposed 
shunt at 3 months, all underwent revision and 1 (1.9%) had 
died by 3 months. In total, 5 (5.7%) of 88 patients under-
went shunt revisions, primarily for exposed shunts.
Three (3.8%) of 79 patients developed meningitis: 1 
in-hospital patient who was lost to follow-up at 3 months 
and 2 patients at the 3-month visit. There were no reported 
wound infections at the 3-month follow-up visit, but the 3 
exposed shunts were considered suspected infections, and 
all patients underwent revisions. At the 3-month follow-up 
visit, only 19 (35.2%) of 54 children were meeting develop-
mental milestones.
Table 3 shows the multivariable analysis of potential 
predictors of all-cause mortality by 3 months after surgery. 
Only older maternal age was significantly associated with 
decreased odds of 3-month mortality (OR 0.9, 95% CI 0.8–
1.0, p = 0.045). This association persisted when excluding 
patients with mothers ≤ 16 years of age but not ≤ 18 years. 
Nonsignificant associations were found for a patient’s age 
at surgery (OR 1.1, 95% CI 0.9–1.2, p = 0.364) and nutri-
tional status (OR 2.0, 95% CI 0.6–6.3, p = 0.256) (Table 3). 
In the ROC curve for the model, the area under the curve 
was 0.6727, showing moderate accuracy of our model to 
predict 3-month mortality. The Hosmer-Lemeshow p value 
was 0.671, indicating adequate model fit (Fig. 2).
Discussion
This study found an in-hospital mortality rate of 5.5% 
and a 3-month mortality rate of 32.1% for children treated 
with VP shunt placement for hydrocephalus in this low-
resource setting. Only younger maternal age was associ-
ated with mortality. Complications such as meningitis, 
shunt exposure, and shunt obstruction were not significant-
ly associated with mortality. Of note, complications and 
mortality were based on family reporting and senior clerk 
examination; thus, follow-up complication rates and causes 
of mortality were sometimes difficult to assess given often-
limited medical knowledge of the families. These results 
suggest that children who undergo VP shunt placement for 
hydrocephalus in Malawi face significant mortality rates 
and high rates of postoperative complications. The asso-
ciation of younger maternal age and increased mortality 
is potentially a proxy for social determinants, which may 
contribute as much to mortality as patient factors. The role 
that social factors play in post-shunting mortality has not 
been previously explored.
Few studies have evaluated morbidity and mortality 
related to VP shunt placement in resource-poor settings. 
Prior investigations similarly found substantial morbidity 
and mortality after shunt placement for hydrocephalus. A 
study of 49 children over the age of 2 years in Nigeria re-
ported a 9.3% shunt infection rate and an overall complica-
tion rate of 28%.8 Of 539 VP shunts inserted in a Kenyan 
hospital, complications occurred in 20%, and 35% failed at 
2 years. Infections occurred in 9.1% of cases, while 11% of 
shunts malfunctioned. The overall 9-month mortality rate 
reported was 7.1%.10 Another Kenyan investigation of 117 
patients over 2 years reported an obstruction rate of 54% 
and infection in 19.7% of patients.16 An older study report-
ed even higher infections rates of 24.6%.17 A study out of 
Ghana reported a complication rate of 34% in 109 patients 
over 2 years, with infections occurring in 14.6% of patients, 
and an overall mortality rate of 4.6%.4 Our mortality rate 
was higher, which may be related to follow-up or to access 
to postoperative care. Of note, the under–5-year-old child 
mortality rates in Malawi for 2017 were 55 per 1000 live 
births compared to 46 in Kenya and 49 in Ghana.28
The reasons for such high morbidity and mortality rates 
in patients with shunts placed for hydrocephalus in this 
limited-resource setting are likely multifactorial. One pos-
sible factor is the variability of the training for the medical 
practitioners performing shunt surgery. At KCH, 2 clinical 
officers, not a neurosurgeon, place VP shunts. Currently, 
there are no standard protocols for placement or training in 
Malawi. Successful placement is likely operator dependent, 
with technical factors potentially increasing infection risk. 
Technical factors and fragile skin both likely contribute to 
shunt exposures. A study in Tanzania of a neurosurgical 
train-forward model suggests that overall neurosurgical 
complications decrease significantly as the health officers’ 
TABLE 3. Multivariable analysis of predictors of all-cause 
mortality by 3 months after surgery
Factor OR (95% CI) p Value
Nutritional status
 Malnourished 2.0 (0.6–6.3) 0.256
 Nourished Reference
Age (mos) 1.1 (0.9–1.2) 0.364
Mother’s age (yrs) 0.9 (0.8–1.0) 0.045
Boldface type indicates statistical significance.
FIG. 2. ROC curve for all-cause mortality by 3 months after surgery.
training progresses, which supports our concern that the 
complication rates after neurosurgical procedures can be 
highly variable depending on the expertise and experience 
of the proceduralist.7
No other studies have looked at social factors contrib-
uting to morbidity and mortality of shunt placement in 
LMICs. However, as our research suggests, these dynamics 
may be critically important. The reason for this associa-
tion between maternal age and mortality remains unclear. 
Younger mothers, particularly teen mothers, may have less 
experience and be less apt to identify abnormal behaviors 
or head circumference changes, resulting in later presenta-
tion for care, as well as untimely identification of postsur-
gical complications after discharge. Younger mothers may 
also be less established socioeconomically, with access to 
fewer resources. While community support often plays a 
role in raising children in Malawi, there may be a cultural 
stigma associated with hydrocephalus that leads to de-
creased attention paid to these children. It is also possible 
that the physical manifestations of hydrocephalus result in 
neglect, particularly for the younger mothers. Indeed, in 
Uganda myelomeningocele patients had higher rates of ne-
glect that may have played a significant role in mortality; 
this may be a significant contributing factor in our hydro-
cephalus patients as well.21
VP shunts are also difficult to manage postoperatively, 
regardless of the available resources. In HICs, shunts re-
quire frequent surveillance and often require revision. In 
LMICs, fewer resources are available to address compli-
cations, and children are more easily lost to follow-up, as 
evidenced by our inability to locate 47% of patients at 6 
months despite multiple strategies to reach them in the 
community.
We conclude that VP shunts are inadequate as a sole 
surgical therapeutic strategy for infant hydrocephalus in 
low-resource settings. Other surgical techniques, such as 
endoscopic third ventriculostomy (ETV) or ETV with cho-
roid plexus cauterization (ETV-CPC), require close follow-
up care for early failure, but they have a very low incidence 
of failure beyond 6 months. ETV-CPC is more difficult to 
perform than VP shunt surgery and requires specialized 
training as well as specialized surgical equipment. While 
ETV-CPC may lead to smaller reductions in ventricle size 
when compared to VP shunts, a recent randomized con-
trolled trial in Uganda demonstrated 12-month cognitive 
outcomes that were equivalent to those of VP shunts.12 Old-
er age, hydrocephalus etiology, and more extensive CPC 
lead to higher success rates, allowing physicians to poten-
tially select patients who would be ideal candidates for the 
procedure.26 Although longer-term data on mortality have 
not been studied in this cohort, the data suggest that af-
ter 3 months, ETV-CPC failure rates remain significantly 
lower than VP shunt rates.11 One study in Ethiopia demon-
strated a 30-day mortality rate of 2.4% after ETV-CPC.1 
In a Ugandan cohort, treatment was successful, at a mean 
follow-up of 31 months, in 82% of patients who underwent 
ETV-CPC, and it remained successful in 72.4% of patients 
at 4 years.24,27 The procedure is effective for postinfectious 
etiologies, which are the majority of cases in low-resource 
settings.14,25
Study Limitations
Limitations of the study include those inherent to any 
descriptive study. We cannot establish true causality and 
opportunity for bias exists, as this is a limited predictive 
model to determine associations. This population is based 
in one region of the country and so may not be generaliz-
able to other regions of the country or other LMICs. Fur-
thermore, there were missing data and loss to follow-up 
at 6 months of 47%, despite significant efforts to locate 
patients, which limited our ability to determine long-term 
morbidity and mortality rates. We did not have enough 
data to evaluate all possible factors related to mortality, 
and reporting regarding complications was difficult given 
parental health literacy, which may lead to information 
bias. The dependence on family reporting to attribute eti-
ology of hydrocephalus and cause of mortality makes reli-
ability uncertain. We do not know what the prevalence of 
hydrocephalus in the community is, as some children may 
not present at all for intervention, leading to selection bias.
Conclusions
This study revealed a high 3-month mortality rate among 
children with hydrocephalus undergoing VP shunt place-
ments in Malawi. Young maternal age was surprisingly a 
significant predictor of mortality. The impact of maternal 
age suggests that social determinants may affect mortality 
as much as patient factors in this limited-resource setting, 
and additional work to identify specific social factors re-
lated to mortality could guide future interventions. Further 
study is needed to determine if VP shunt placement can 
be optimized and mortality lowered in this resource-poor 
setting. Consideration of alternative therapies must also be 
contemplated given these high rates of mortality.
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